EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transcatheter arterial embolization in patients with neuroendocrine neoplasms related to liver metastasis with different blood supplies

Jianan Bai, Jinhua Song, Yang Zhang, Xiaolin Li, Lijun Yan iD, Ping Hu, Qiyun Tang iD

Cancer Medicine · 2023

DOI: 10.1002/cam4.6464 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Jianan Bai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Gastroenterology, The First Affiliated Hospital with Nanjing Medical University, Institute of Neuroendocrine Tumor, Nanjing M…. Hauptthemen laut MEDLINE: Liver Neoplasms, Embolization, Therapeutic, Neuroendocrine Tumors, Pancreatic Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Medical Award Foundation, the New Clinical Technology Research in Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Liver metastasis is one of the most important factors affecting the prognosis of patients with neuroendocrine neoplasms (NENs). Transhepatic artery embolization (TAE) is the main local treatment of NENs with liver metastasis (NENLM). This study aimed to elucidate the differences between pancreatic and rectal NENLM with a discrepancy in blood supply.

Methods

A total of 32 patients with NENLM of different primary sites received 102 TAE treatments at our hospital. Clinical features, such as age, sex, World Health Organization (WHO) tumour grade and progression‐free survival (PFS), were compared between patients with pancreatic and rectal NENLM with different blood supplies. The total follow‐up time is 1–5 years.

Results

There were 12 cases with tumours originating from the rectum or pancreas, respectively. Other tumour‐originated sites included the duodenum (two cases, 6.25%), the thymus and lung (four cases, 12.5%), and the unknown (two cases, 6.25%). The average age of patients was 51.59 years, and 17 (53.1%) were men. WHO grade 1, 2 or 3 tumours occurred in three (9.4%), 23 (71.9%) and six (18.7%) patients, respectively. Hepatic tumour burdens of low (50%) levels were found in 13 (40.6%), eight (25%) and 11 (34.4%) patients, respectively. There were more patients with hypervascular pancreatic NENLM than with hypovascular rectal NENLM ( p = 0.005). Tumour shrinkage in all cases with NENLM was 50% with an objective response rate of 37.5%, disease control rate of 75% and PFS of 12 months. Disease progression ( p = 0.09), tumour shrinkage ( p = 0.07) and death ( p = 0.19) were more prominent in the pancreatic NENLM group than in the rectal NENLM group. Progression‐free survival was not reached in the pancreatic NENLM group, which was more prominent than in the rectal NENLM group (7 months; hazard ration, 0.22; 95% confidence interval, 0.07–0.76; p = 0.016). The main adverse events were abdominal pain (71.9%) and transaminase elevation (50%), which were more common in pancreatic NENLM than in rectal NENLM.

Conclusions

Transhepatic artery embolization treatment is markedly effective and safe for treating NENLM, especially pancreatic NENLM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsEmbolization, TherapeuticNeuroendocrine TumorsPancreatic NeoplasmsRectal NeoplasmsHumansMaleFemaleMiddle AgedAgedAdultRetrospective StudiesProgression-Free SurvivalTreatment Outcome

Stichwörter der Autor:innen

adverse eventsblood supplyliver metastasisneuroendocrine neoplasmprogression-free survivaltranshepatic artery embolization

Autor:innen und Institutionen

  • Department of Geriatric Gastroenterology, The First Affiliated Hospital with Nanjing Medical University, Institute of Neuroendocrine Tumor, Nanjing Medical University, Nanjing, China.
  • Department of Hepatobiliary Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.

ORCID-Profile: Lijun Yan, Qiyun Tang

Förderung

  • Beijing Medical Award Foundation
  • the New Clinical Technology Research in Jiangsu Province

Zitieren

APA

Bai, J., Song, J., Zhang, Y., Li, X., Yan, L., Hu, P., & Tang, Q. (2023). Transcatheter arterial embolization in patients with neuroendocrine neoplasms related to liver metastasis with different blood supplies. Cancer Medicine. https://doi.org/10.1002/cam4.6464

Vancouver

Bai J, Song J, Zhang Y, Li X, Yan L, Hu P, et al. Transcatheter arterial embolization in patients with neuroendocrine neoplasms related to liver metastasis with different blood supplies. Cancer Medicine. 2023. doi:10.1002/cam4.6464

BibTeX
@article{Bai2023,
  author = {Bai, Jianan and Song, Jinhua and Zhang, Yang and Li, Xiaolin and Yan, Lijun and Hu, Ping and Tang, Qiyun},
  title = {Transcatheter arterial embolization in patients with neuroendocrine neoplasms related to liver metastasis with different blood supplies},
  journal = {Cancer Medicine},
  year = {2023},
  doi = {10.1002/cam4.6464}
}
Kostenlos starten →